KLOW peptide is not a single compound. It is a name used for a blend of four research peptides: BPC-157, TB-500, GHK-Cu and KPV [1]. Each of the four has its own body of research, mostly in cells and animals, but no published study has tested the KLOW blend itself.
This guide explains what is in KLOW, what each ingredient has been studied for, and what is still unknown.
Key takeaways
- KLOW combines four peptides that are studied separately for tissue repair, skin and inflammation.
- Most of the research on these ingredients comes from cell and animal studies. Human data is very limited.
- KLOW is GLOW plus one extra peptide, KPV.
- Two of its ingredients, BPC-157 and TB-500, are banned in sport at all times.
What Is KLOW Peptide?
KLOW is a trade-style name, not a scientific one. You will see it listed and searched as KLOW, KLOW blend, KLOW peptides, or the KLOW stack, but in each case it refers to the same four ingredients.
Two words come up a lot here:
- Blend: the peptides are mixed together and supplied in one vial.
- Stack: the peptides are kept separate but studied or discussed as a group.
KLOW builds on an older pairing. BPC-157 and TB-500 together are often called the wolverine stack, and KLOW adds GHK-Cu and KPV to that pair.
What Is in KLOW Peptide?
KLOW contains four peptides. A peptide is a short chain of amino acids, the same building blocks that make up proteins.
| Ingredient | What it is, in plain words | Main research area | Type of evidence |
|---|---|---|---|
| BPC-157 | A 15-amino-acid peptide first found in stomach juice | Tissue and tendon repair | Mostly animal studies |
| TB-500 | A 7-amino-acid piece of a larger protein called thymosin beta-4 | Wound healing, cell movement | Cell and animal studies |
| GHK-Cu | A 3-amino-acid peptide bound to copper, found naturally in human blood | Skin, collagen, wound healing | Cell, animal and some human topical studies |
| KPV | A 3-amino-acid piece of the hormone alpha-MSH | Inflammation, mainly in the gut | Cell and animal studies |
Sources for this table: [2], [3], [4], [5].
BPC-157
BPC-157 is a 15-amino-acid peptide derived from a protein in gastric juice. It is the best-known ingredient in the blend, and most research on BPC-157 has looked at muscle, tendon and other tissue in animals [2].
TB-500
TB-500 is a short piece of thymosin beta-4, matching amino acids 17 to 23 of that protein. Thymosin beta-4 binds actin, a structural protein inside cells [3]. Think of actin as the scaffolding inside a cell: thymosin beta-4 helps control how that scaffolding is built and taken apart.
GHK-Cu
GHK-Cu is a tiny peptide made of three amino acids (glycine, histidine, and lysine) that holds a copper ion. It was identified in human plasma in 1973, and its level in the blood falls from about 200 ng/mL at age 20 to about 80 ng/mL at age 60. Most human studies of the GHK-Cu copper peptide have used products applied to the skin [4].
KPV
KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), a natural hormone. Research on the KPV peptide has focused mainly on inflammation in the gut, so far in mice [5].
What Is KLOW Peptide Used For in Research?
People searching for KLOW peptide benefits usually want to know what the blend does. The honest answer is that the blend has no research of its own, so any “benefits” come from studies of the four ingredients one at a time. Researchers are mainly interested in three areas:
- Tissue repair: BPC-157 and TB-500
- Skin and collagen: GHK-Cu
- Inflammation: KPV
Here is what one key study or review found for each ingredient:
| Ingredient | Study | Study type | What was found |
|---|---|---|---|
| BPC-157 | Vasireddi et al., 2025 [2] | Systematic review of 36 studies | 35 were animal or lab studies. The only human study was a small look-back study of 12 people with knee pain. The authors said human safety is unknown. |
| TB-500 | Product research summary [3] | Cell and mouse studies | Applied to the skin of mice, TB-500 was linked to faster wound healing. |
| GHK-Cu | Pickart and Margolina, 2018 [4] | Review of cell, animal and human topical studies | Studies point to roles in skin repair and wound healing. |
| KPV | Kannengiesser et al., 2008 [5] | Animal study in mice | Mice with gut inflammation given KPV showed less inflammation and regained weight sooner. |
A systematic review is a study that gathers and grades all earlier research on a topic. A look-back (retrospective) study reviews past records instead of testing something new, which makes it weaker evidence.
Has the KLOW Blend Itself Been Studied?
We found no published study that tested BPC-157, TB-500, GHK-Cu and KPV together as one blend. That matters for two reasons:
- Effects may not add up. Results seen with each peptide alone do not tell you how they behave when mixed.
- Safety is untested. No study has looked at how the four interact with each other in the same sample.
A simple comparison: four ingredients that each work in a recipe on their own still need to be tested together before anyone knows how the dish turns out.
KLOW vs GLOW: What Is the Difference?
KLOW and GLOW share three ingredients. KLOW simply adds KPV [1].
| Ingredient | GLOW | KLOW |
|---|---|---|
| BPC-157 | Yes | Yes |
| TB-500 | Yes | Yes |
| GHK-Cu | Yes | Yes |
| KPV | No | Yes |
So when people compare KLOW vs GLOW peptide, the real question is what KPV adds. Based on current research, that is a peptide studied mainly for inflammation in animal models.
KLOW Peptide Side Effects and Safety
There is no side effect data for the KLOW blend, because it has not been studied as a blend. What we do know comes from the ingredients:
| Ingredient | What is known about safety |
|---|---|
| BPC-157 | A 2025 review concluded that its safety in humans is unknown [2] |
| TB-500 | Research suppliers label it “not for human or veterinary use” [3] |
| GHK-Cu | Human studies have mostly used products applied to the skin [4] |
| KPV | Data comes from animal studies [5] |
So if you are asking whether KLOW peptide is safe, the evidence cannot answer that yet. The gap is not proof of harm, but it is also not proof of safety.
Is KLOW Banned in Sport?
Yes, in practice. Two of its four ingredients appear on the anti-doping list that follows the World Anti-Doping Agency (WADA) rules for 2026 [6]:
- BPC-157 is named under S0, the class for non-approved substances.
- TB-500 is named under S2, as a derivative of thymosin beta-4.
Both classes are prohibited at all times, in and out of competition. GHK-Cu and KPV are not named on the list.
Where Do Researchers Source KLOW?
For laboratory studies, researchers source peptide blends like KLOW from specialized suppliers that provide compounds strictly for research use. With a four-ingredient blend, quality checks matter even more, because each peptide needs to be confirmed. Research teams usually look for:
- Batch purity testing, which shows how much of the vial is the intended peptides and how much is something else
- A certificate of analysis (COA), a lab report that confirms the identity and amount of each ingredient in the batch
- Clear research-use-only labeling on every product
Researchers often source peptides from trusted platforms such as PeptidePro, which supplies research compounds for laboratory and scientific study. All such compounds are intended for research purposes only and not for human consumption.
Frequently Asked Questions
What exactly is KLOW peptide?
KLOW peptide is a blend of four research peptides: BPC-157, TB-500, GHK-Cu and KPV. It is a trade-style name rather than a single compound. Each ingredient has been studied on its own, mostly in cells and animals, but the blend as a whole has not been tested in published research.
What are the side effects of taking KLOW peptide?
No study has reported side effects for the KLOW blend, because the blend itself has not been studied. A 2025 review found that the safety of BPC-157 in humans is unknown, and data for TB-500 and KPV comes from lab and animal work. Missing data means the risks are not known.
What is the difference between KLOW and GLOW?
GLOW contains three peptides: BPC-157, TB-500 and GHK-Cu. KLOW contains those same three plus KPV, a small peptide taken from the hormone alpha-MSH. KPV has been studied mainly for gut inflammation in mice, so the difference between the two blends comes down to that one ingredient.
Has KLOW been tested in humans?
Not as a blend. We found no published human or animal study of the four peptides combined. Human data for the individual ingredients is also thin: a 2025 review of BPC-157 found just one small human study, and most human research on GHK-Cu has used products applied to the skin.
Is KLOW peptide banned in sports?
Two of its ingredients are. BPC-157 is listed under S0 and TB-500 under S2 on the 2026 anti-doping list, and both classes are prohibited in and out of competition. GHK-Cu and KPV are not named. Because the blend contains banned ingredients, it falls under the same rules.
Disclaimer
This article is provided for educational and informational purposes only and does not constitute medical advice. The compounds discussed are research compounds and are not intended for human consumption. Anyone considering the use of any peptide should first consult a qualified, licensed healthcare professional, who can assess their individual circumstances and advise on what is most appropriate for them.
References
- Superpower. GLOW peptide guide, which describes KLOW as GLOW plus KPV.
- Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS Journal. 2025;21(4):485-495.
- Cayman Chemical. TB-500 (acetate) product information.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018;19(7):1987.
- Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(3):324-331.
- Voluntary Anti-Doping Association. VADA Prohibited List 2026, which tracks the WADA 2026 Prohibited List.